1335210-23-5
1335210-23-5
Chemical Structure
Dolutegravir intermediate-1
- CAS No.: 1335210-23-5
- Formula:C13H17NO8
- Molecular Weight:315.28
IUPAC Name: 1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid
InChIKey: XAXGEECGULRZGN-UHFFFAOYSA-N
SMILES: O=C(C1=C(OC)C(C(C(O)=O)=CN1CC(OC)OC)=O)OC
Biological Activity: Dolutegravir intermediate-1 (Compound 11) is a synthetic intermediate. Dolutegravir intermediate-1 can be used to synthesize Dolutegravir (HY-13238). Dolutegravir is an Integrase inhibitor with potential applications in HIV-1 infection research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Dolutegravir intermediate-1 | 99.95% | Dolutegravir intermediate-1 (Compound 11) is a synthetic intermediate. Dolutegravir intermediate-1 can be used to synthesize Dolutegravir (HY-13238). Dolutegravir is an Integrase inhibitor with potential applications in HIV-1 infection research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dolutegravir intermediate-1 (Standard) | ≥98% | Dolutegravir intermediate-1 (Standard) is the analytical standard of Dolutegravir intermediate-1 (HY-100083). This product is intended for research and analytical applications. Dolutegravir intermediate-1 is a synthetic intermediate of Dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
